DaVita Clinical Research to Present Research Results on Hospital Readmissions, Anemia Management, Nutrition

  DaVita Clinical Research to Present Research Results on Hospital
  Readmissions, Anemia Management, Nutrition

Business Wire

ORLANDO, Fla. -- April 04, 2013

DaVita Clinical Research^® (DCR^®), a specialty contract research organization
with services spanning the full spectrum of drug and device development, today
announced that company representatives will present four abstracts at National
Kidney Foundation's (NKF) 2013 Spring Clinical Meeting, which takes place
April 2-6, 2013, in Orlando, Fla.

The NKF Spring Clinical Meeting is a platform for the nation's leading renal
health care providers to learn about new developments in the field of
nephrology and kidney care practices.

Researchers from DaVita^®, the dialysis division of DaVita Healthcare Partners
Inc., and DCR will present results from a number of innovative clinical
improvement programs originating from DaVita and its research partners. DCR
provides a collaborative bridge between DaVita’s health care community and the
academic, pharmaceutical and biotech research community. DCR and DaVita share
a dedication to improving the health and quality of life for kidney care
patients.

DCR’s recent research includes analyses of hospital readmissions and length of
stay, new findings on anemia management and work on nutritional issues.

“Clinical research is a critical part of DaVita’s work to alleviate suffering
and reduce health care costs related to chronic kidney disease and end stage
renal disease,” said Mahesh Krishnan, M.D., M.P.H., M.B.A., F.A.S.N., vice
president of clinical research. “These abstracts are the result of significant
investments in clinical research, and we believe the findings demonstrate the
value of that investment.”

At this year's NKF Spring Clinical Meeting, DaVita will focus on several key
research initiatives in end-stage renal disease, including:

  *“Analysis of Length of Stay (LOS) and Readmissions Among End-Stage Renal
    Disease (ESRD) and Non-ESRD Patients Using a 5% Sample of Inpatient Claims
    Data From the Centers for Medicare and Medicaid Services (CMS)
    (2007-2008)”[Poster 128]
  *“Evaluating Hemoglobin (HB) Trends and the Potential Impact on
    Transfusions (TFNS) Under the New ESA Guidelines in Patients with ESRD at
    a Large Dialysis Organization” [Poster 48]
  *“Timing of Albumin Testing Affects Corrected Calcium Levels” [Poster 115]
  *“Multiple Anemia Protocols Permit Anemia Control and Physician Choice”
    [Poster 48]

DaVita, DaVita Clinical Research, DCR and DaVita HealthCare Partners are
trademarks or registered trademarks of DaVita Healthcare Partners Inc. All
other trademarks are the property of their respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune
500® company that, through its operating divisions, provides a variety of
health care services to patient populations throughout the United States and
abroad. A leading provider of kidney care in the United States, DaVita
delivers dialysis services to patients with chronic kidney failure and end
stage renal disease. DaVita strives to improve patients’ quality of life by
innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of
Dec.31, 2012, DaVita operated or provided administrative services at 1,954
outpatient dialysis centers located in the United States serving approximately
153,000 patients. The company also operated 36 outpatient dialysis centers
located in eight countries outside the United States. DaVita supports numerous
programs dedicated to creating positive, sustainable change in communities
around the world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern Healthcare,
Newsweek and WorldBlu. For more information, please visit DaVita.com.

About DaVita Clinical Research

DaVita Clinical Research(DCR), a wholly owned subsidiary ofDaVita HealthCare
Partners Inc., uses its extensive, applied database and real-world healthcare
experience to assist pharmaceutical and medical device companies in the
design, recruitment, and completion of clinical trials including retrospective
and prospective pragmatic trials.DCR’s scientific and clinical expertise
spans the lifecycle of product development with more than 150 client
companies. DCR’sBiorepository,Early Clinical Researchunit (Phase I-IIa)
andClinical Development (Phase IIb through post-marketing)network of
physicians and investigative sites, data research,Health Economics & Outcomes
Research,Central Laboratory, andMedical Communicationsare focused on
providing world-class research in both complex/specialty populations and
therapeutic areas, and especially in CKD and ESRD populations. To learn more
about DCR, visitwww.davitaclinicalresearch.com.

Contact:

DaVita Clinical Research
Bianca Violante
Office: 303-876-661
Mobile: 443-417-6044
Bianca.Violante@DaVita.com
 
Press spacebar to pause and continue. Press esc to stop.